Effect of all-trans retinoic acid on drug sensitivity and expression of survivin in LoVo cells / 中华医学杂志(英文版)
Chinese Medical Journal
; (24): 331-335, 2008.
Article
в En
| WPRIM
| ID: wpr-287738
Ответственная библиотека:
WPRO
ABSTRACT
<p><b>BACKGROUND</b>All-trans retinoic acid (ATRA) can influence the tumor cell proliferation cycle, and some chemotherapeutic drugs are cycle specific. In this study, we hypothesize that ATRA can enhance chemotherapeutic drug sensitivity by affecting the cell cycle of tumor cells.</p><p><b>METHODS</b>The cell cycle of LoVo cells was evaluated using flow cytometry (FCM). Cell viability was analyzed using the MTT assay. The morphologic changes in the treated LoVo cells were measured with acridine orange (AO)/ethidium bromide (EB) staining. Expression of survivin in LoVo cells was analyzed by immunofluorescence assay.</p><p><b>RESULTS</b>After LoVo cells were treated with ATRA, the G0/G1 ratio of the tumor cells increased and the cell ratio of S- and G2/M-phase decreased. Viability of the cells decreased significantly after combined treatment with ATRA and 5-fluorouracil (5-FU) or mitomycin c (MMC) and was evaluated by fluorescence microscopy. Expression level of survivin in the tumor cells decreased after ATRA combination treatment.</p><p><b>CONCLUSIONS</b>ATRA enhances drug sensitivity of the LoVo cell line to cell cycle-specific agents and inhibits the expression of survivin in LoVo cells. The combination of ATRA and 5-FU or MMC promoted cell apoptosis, and the mechanism involved in apoptosis may be related to inhibition of survivin gene expression.</p>
Полный текст:
1
База данных:
WPRIM
Основная тема:
Pharmacology
/
Tretinoin
/
Gene Expression Regulation, Neoplastic
/
Colonic Neoplasms
/
Drug Resistance, Neoplasm
/
Cell Line, Tumor
/
Drug Therapy
/
Inhibitor of Apoptosis Proteins
/
Flow Cytometry
/
Genetics
Пределы темы:
Humans
Язык:
En
Журнал:
Chinese Medical Journal
Год:
2008
Тип:
Article